Druggio
|
Made by
Active Ingredient
Sebelipase alfa
Prospectus
Approval date
2016/3/28
Treats
Dosages
Sebelipase Alfa(Genetical Recombination)KANUMA for Intravenous Infusion 20mg - 1301517円/瓶